InvaGen Pharmaceuticals, Inc. SEC EDGAR Filings (CIK 0001759453)

SEC EDGAR filings, ownership reports, and insider transactions for InvaGen Pharmaceuticals, Inc..

Business address
Site B, 7 Oser Ave., Hauppauge, NY, 11788
State of incorporation
NY
Fiscal year end
31 March
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
InvaGen Pharmaceuticals, Inc. has filed 6 SEC EDGAR filings since 23 Nov 2018

Latest Filings

Recent SEC filings for InvaGen Pharmaceuticals, Inc. including SC 13D/A, 4, 3 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SC 13D/A 19 Oct 2022
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 13 Oct 2022 11 Oct 2022 001-38114
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SC 13D/A 28 Jul 2022
3 Open 3 document View SEC filing for 3 FORM 3 31 Dec 2019 08 Feb 2019 001-38114
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SC 13D/A 11 Feb 2019
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 23 Nov 2018

About this filer

InvaGen Pharmaceuticals, Inc. files with the SEC under CIK 0001759453. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages